SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark

Int J Infect Dis. 2021 Nov:112:96-102. doi: 10.1016/j.ijid.2021.09.023. Epub 2021 Sep 15.

Abstract

Objective: Healthcare workers (HCWs) carry a pronounced risk of acquiring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of this study was to determine the seroprevalence and potential risk factors of SARS-CoV-2 infection among HCWs in the Region of Southern Denmark after the first pandemic wave in the spring of 2020.

Methods: This was an observational study conducted between May and June 2020. SARS-CoV-2 IgG and IgM antibodies were measured in plasma. Participants were asked to complete a questionnaire consisting of demographic information, risk factors, and COVID-19-related symptoms.

Results: A total of 7950 HCWs participated. The seroprevalence of SARS-CoV-2 antibodies was 2.1% (95% confidence interval (CI) 1.8-2.4%). Seropositive participants were significantly older (mean age 48.9 years vs 46.7 years in seronegative participants, P = 0.022) and a higher percentage had experienced at least one symptom of COVID-19 (P < 0.001). The seroprevalence was significantly higher among HCWs working on dedicated COVID-19 wards (3.5%; OR 2.02, 95% CI 1.44-2.84). Seroprevalence was significantly related to 11-50 close physical contacts per day outside work (OR 1.54, 95% CI 1.07-2.22).

Conclusions: The prevalence of SARS-CoV-2 antibodies was low in HCWs. However, the occupational risk of contracting the infection was found to be higher for those working on dedicated COVID-19 wards. Further, the results imply that attention should be paid to occupational risk factors in planning pandemic preparedness.

Keywords: Antibodies; COVID-19; Epidemiology; Healthcare workers; SARS-CoV-2; Seroprevalence.

Publication types

  • Observational Study

MeSH terms

  • Antibodies, Viral
  • COVID-19*
  • Denmark / epidemiology
  • Health Personnel
  • Humans
  • Middle Aged
  • SARS-CoV-2*
  • Seroepidemiologic Studies

Substances

  • Antibodies, Viral